A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer

BACKGROUND: We evaluated the efficacy and safety of the modified FOLFOX6 (mFOLFOX6) regimen as a neoadjuvant chemotherapy in gastric cancer patients. METHODS: Seventy-three patients with T2–T4 or N+ were enroled. Preoperative chemotherapy consisted of three cycles of mFOLFOX6. The primary end points...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Cancer
Autori principali: Wang, Xiang, Zhao, Lin, Liu, Hongfeng, Zhong, Dingrong, Liu, Wei, Shan, Guangliang, Dong, Fen, Gao, Weisheng, Bai, Chunmei, Li, Xiaoyi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2016
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984457/
https://ncbi.nlm.nih.gov/pubmed/27172250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.126
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi